Cargando…
Molecular Basis of Late-Life Depression
Late-life depression (LLD), compared to depression at a young age, is more likely to have poor prognosis and high risk of progression to dementia. A recent systemic review and meta-analysis of the present antidepressants for LLD showed that the treatment response rate was 48% and the remission rate...
Autores principales: | Kuo, Chien-Yi, Lin, Chieh-Hsin, Lane, Hsien-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303929/ https://www.ncbi.nlm.nih.gov/pubmed/34299040 http://dx.doi.org/10.3390/ijms22147421 |
Ejemplares similares
-
From Menopause to Neurodegeneration—Molecular Basis and Potential Therapy
por: Cheng, Yu-Jung, et al.
Publicado: (2021) -
Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2022) -
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021) -
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
por: Huang, Yu-Jhen, et al.
Publicado: (2017) -
Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design
por: Lin, Eugene, et al.
Publicado: (2020)